Shuzhong Cui

4.8k total citations · 2 hit papers
91 papers, 2.9k citations indexed

About

Shuzhong Cui is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shuzhong Cui has authored 91 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 26 papers in Cancer Research and 24 papers in Surgery. Recurrent topics in Shuzhong Cui's work include Intraperitoneal and Appendiceal Malignancies (17 papers), MicroRNA in disease regulation (13 papers) and Cancer-related molecular mechanisms research (11 papers). Shuzhong Cui is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (17 papers), MicroRNA in disease regulation (13 papers) and Cancer-related molecular mechanisms research (11 papers). Shuzhong Cui collaborates with scholars based in China, United States and Australia. Shuzhong Cui's co-authors include Hongsheng Tang, Lisi Zeng, Xiangliang Zhang, Mengyu Chang, Jun Lin, Binbin Ding, Zhiyao Hou, Meifang Wang, Man Wang and Chunxia Li and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shuzhong Cui

87 papers receiving 2.9k citations

Hit Papers

A Multifunctional Cascade... 2019 2026 2021 2023 2019 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuzhong Cui China 25 1.4k 884 699 668 455 91 2.9k
Prakash Gangadaran South Korea 34 2.4k 1.7× 1.1k 1.3× 674 1.0× 509 0.8× 644 1.4× 129 4.1k
Qichun Wei China 30 1.2k 0.8× 487 0.6× 523 0.7× 903 1.4× 568 1.2× 138 3.2k
Shuo Wang China 35 2.0k 1.4× 502 0.6× 713 1.0× 915 1.4× 834 1.8× 141 3.8k
Xiaoyu Liang China 28 1.3k 0.9× 422 0.5× 561 0.8× 454 0.7× 853 1.9× 65 2.7k
Wanhai Xu China 35 1.8k 1.3× 735 0.8× 892 1.3× 519 0.8× 332 0.7× 139 3.5k
Chun‐Wei Peng China 29 1.0k 0.7× 525 0.6× 396 0.6× 660 1.0× 230 0.5× 64 2.3k
Deliang Fu China 28 994 0.7× 621 0.7× 482 0.7× 1.3k 2.0× 279 0.6× 99 2.7k
Ciprian Tomuleasa Romania 26 1.3k 0.9× 675 0.8× 330 0.5× 552 0.8× 336 0.7× 181 2.6k
Chang Zou China 33 2.1k 1.5× 1.1k 1.2× 451 0.6× 997 1.5× 499 1.1× 120 3.9k
Behzad Baradaran Iran 28 1.4k 1.0× 664 0.8× 773 1.1× 757 1.1× 659 1.4× 113 2.9k

Countries citing papers authored by Shuzhong Cui

Since Specialization
Citations

This map shows the geographic impact of Shuzhong Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuzhong Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuzhong Cui more than expected).

Fields of papers citing papers by Shuzhong Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuzhong Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuzhong Cui. The network helps show where Shuzhong Cui may publish in the future.

Co-authorship network of co-authors of Shuzhong Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Shuzhong Cui. A scholar is included among the top collaborators of Shuzhong Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuzhong Cui. Shuzhong Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Ziying, Yue Wang, Jiali Luo, et al.. (2025). Hyperthermic intraperitoneal chemotherapy after upfront cytoreductive surgery for stage III epithelial ovarian cancer: Follow‐up of long‐term survival. Acta Obstetricia Et Gynecologica Scandinavica. 104(5). 988–997. 1 indexed citations
3.
Hao, Jian, Yan Fu, Xiaoyang Liu, et al.. (2024). Genetic Association of Juvenile Idiopathic Arthritis With Adult Rheumatic Disease. JAMA Network Open. 7(12). e2451341–e2451341. 1 indexed citations
4.
Cui, Shuzhong, et al.. (2024). Hsa_circ_0051908 Promotes Hepatocellular Carcinoma Progression by Regulating the Epithelial–Mesenchymal Transition Process. Analytical Cellular Pathology. 2024(1). 8645534–8645534. 1 indexed citations
5.
Li, Zhouyu, et al.. (2022). Optimizing the IPSA Conditions to Improve the Treatment Plan Quality in Brachytherapy for Cervical Cancer. Journal of Oncology. 2022. 1–13. 1 indexed citations
6.
Zhang, Ying, Lisi Zeng, Juan Wang, et al.. (2021). Multifunctional Non-Coding RNAs Mediate Latent Infection and Recurrence of Herpes Simplex Viruses. Infection and Drug Resistance. Volume 14. 5335–5349. 5 indexed citations
7.
Zhou, Yang, Jun-Ting Cheng, Yingying Wang, et al.. (2021). Could gastrointestinal tumor-initiating cells originate from cell-cell fusionin vivo?. World Journal of Gastrointestinal Oncology. 13(2). 92–108. 1 indexed citations
8.
Yang, Xianzi, Ximin Chen, Lisi Zeng, et al.. (2020). Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma. Aging. 12(20). 20380–20395. 13 indexed citations
9.
Cui, Bin, Yingying Wang, Jun-Ting Cheng, et al.. (2020). The old CEACAMs find their new role in tumor immunotherapy. Investigational New Drugs. 38(6). 1888–1898. 32 indexed citations
10.
Li, Huan, Ze Yu, Run Shi, et al.. (2020). Tumor Necrosis Factor α Reduces SNAP29 Dependent Autolysosome Formation to Increase Prion Protein Level and Promote Tumor Cell Migration. Virologica Sinica. 36(3). 458–475. 8 indexed citations
11.
Wang, Wenjuan, Zihou Deng, Hongyu Wu, et al.. (2019). A small secreted protein triggers a TLR2/4-dependent inflammatory response during invasive Candida albicans infection. Nature Communications. 10(1). 1015–1015. 59 indexed citations
12.
Wang, Yingying, Hong-Yi Xin, Jun-Ting Cheng, et al.. (2019). Identification of Putative UL54 (ICP27) Transcription Regulatory Sequences Binding to Oct-1, v-Myb, Pax-6 and Hairy in Herpes Simplex Viruses. Journal of Cancer. 10(2). 430–440. 15 indexed citations
13.
Zeng, Lisi, Quanxing Liao, Zhaowei Zou, et al.. (2018). Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway. Cellular Physiology and Biochemistry. 51(3). 1221–1236. 49 indexed citations
14.
Yang, Xianzi, Tiantian Cheng, Qingjun He, et al.. (2018). LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway. Molecular Cancer. 17(1). 126–126. 310 indexed citations
15.
Ba, Mingchen, et al.. (2017). Mild hyperthermia enhances sensitivity of gastric cancer cells to chemotherapy through reactive oxygen species–induced autophagic death. Tumor Biology. 39(6). 3726132795–3726132795. 12 indexed citations
16.
Ba, Mingchen, Hui Long, Xiangliang Zhang, et al.. (2016). Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients with Malignant Ascites Secondary to Unresectable Gastric Cancer. Journal of Laparoendoscopic & Advanced Surgical Techniques. 26(1). 32–39. 4 indexed citations
18.
Tu, Yinuo, Yunhong Tian, Zhiyuan Fang, et al.. (2016). Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion for the treatment of gastric cancer: A single-centre retrospective study. International Journal of Hyperthermia. 32(6). 587–594. 10 indexed citations
19.
Zhang, Xiangliang, et al.. (2015). MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy. Oncology Reports. 34(3). 1557–1564. 70 indexed citations
20.
Zhang, Xiangliang, Huijuan Shi, Hongsheng Tang, et al.. (2015). miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. International Journal of Molecular Medicine. 35(5). 1301–1308. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026